Amphiphilic polylactic acid-hyperbranched polyglycerol nanoparticles as a controlled release system for poorly water-soluble drugs: Physicochemical characterization

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 6, 2011, Pages 757-764

  Gao, Xiujun ^a   Zhang, Xinge ^a   Zhang, Xuejiao ^a   Wang, Yanxia ^a   Sun, Lei ^a   Li, Chaoxing ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

amphiphilic copolymer; biodegradation; controlled release; cytocompatibility; hydrophobic drug

Indexed keywords

COPOLYMER; GLYCEROL; HYPERBRANCHED POLYGLYCEROL; NANOPARTICLE; POLYLACTIC ACID; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NANOENCAPSULATION; PHYSICAL CHEMISTRY; WATER ABSORPTION; X RAY POWDER DIFFRACTION;

3T3 CELLS; ANIMALS; CELL SURVIVAL; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; GLYCEROL; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; MICE; NANOCAPSULES; PARTICLE SIZE; POLYMERS; QUERCETIN; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 79956199952     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01260.x     Document Type: Article

References (45)

1. Kaldas MI, et al,. Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem 2005; 53: 4194-4197. (Pubitemid 40936783)
2. Kandaswami C, et al,. The antitumor activities of flavonoids. In Vivo 2005; 19: 895-909.
3. Comalada M, et al,. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappa B pathway. Eur J Immunol 2005; 35: 584-592. (Pubitemid 40331335)
4. Ratnam DV, et al,. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 2006; 113: 189-207. (Pubitemid 43983041)
5. Park CH, et al,. Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 2005; 328: 227-234. (Pubitemid 40164659)
6. Vijayababu MR, et al,. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 2005; 131: 765-771. (Pubitemid 41577954)
7. Yang JH, et al,. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 2006; 34: 296-304.
8. Lee LT, et al,. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 2002; 22: 1615-1627.
9. Niina MM, et al,. Plant flavonol quercetin and isoflavone biochanin A differentially induce protection against oxidative stress and inflammation in ARPE-19 cells. Food Res Int 2011; 44: 109-113.
10. Kuo SM,. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996; 110: 41-48.
11. Jakubowicz-Gil J, et al,. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol 2005; 69: 1343-1350.
12. Asaum J, et al,. Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin. Anticancer Res 2000; 20: 2477-2483. (Pubitemid 30614455)
13. Cipák L, et al,. Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells. Leuk Res 2003; 27: 65-72. (Pubitemid 35449718)
14. Chan MM, et al,. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 2003; 194: 63-70. (Pubitemid 35424228)
15. Li HL, et al,. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009; 133: 238-244.
16. Chattopadhyay P, et al,. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007; 59: 444-453. (Pubitemid 47259225)
17. Kumar VV, et al,. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm 2007; 335: 167-175. (Pubitemid 46482862)
18. Zhang Y, et al,. Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci 2008; 107: 891-897. (Pubitemid 350241650)
19. Xing J, et al,. Studies on the oridonin-loaded poly (D,L-lactic acid) nanoparticles in vitro and in vivo. Int J Biol Macromol 2007; 40: 153-158. (Pubitemid 46027243)
20. Derakhshandeh K, et al,. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm 2007; 66: 34-41. (Pubitemid 46412968)
21. Gottschalk C, et al,. Multi-arm star poly (L-lactide) with hyperbranched polyglycerol core. Macromol Chem Phys 2007; 208: 1657-1665. (Pubitemid 47294047)
22. Gao X, et al,. Synthesis and physicochemical characterization of a novel amphiphilic polylactic acid-hyperbranched polyglycerol conjugate for protein delivery. J Control Release 2009; 140: 141-147.
23. Rakesh KT, et al,. Dendrimers in oncology: an expanding horizon. Chem Rev 2009; 109: 49-87.
24. Hecht S, et al,. Light driven catalysis within dendrimers: designing amphiphilic singlet oxygen sensitizers. J Am Chem Soc 2001; 123: 6959-6960. (Pubitemid 32884570)
25. Stiriba S-E, et al,. Hyperbranched molecular nanocapsules: comparison of the hyperbranched architecture with the perfect linear analogue. J Am Chem Soc 2002; 124: 9698-9699.
26. Liu CH, et al,. Honeycomb-patterned photoluminescent films fabricated by self-assembly of hyperbranched polymers. Angew Chem Int Ed 2007; 46: 4128-4131.
27. Liu CH, et al,. Synergetic supramolecular encapsulation of amphiphilic hyperbranched polymer to dyes. Macromolecules 2006; 39: 8102-8111.
28. Wang DC, et al,. Macromolecular nanocapsule derived from hyperbranched polyethylenimine (HPEI): mechanism of guest encapsulation versus molecular parameters. Macromolecules 2009; 42: 1533-1540.
29. Sunder A, et al,. Controlled synthesis of hyperbranched polyglycerols by ring-opening multibranching polymerization. Macromolecules 1999; 32: 4240-4246.
30. Kainthan RK, et al,. Biocompatibility testing of branched and linear polyglycidol. Biomacromolecules 2006; 7: 703-709.
31. Marubayashi H, et al,. Crystalline structure and morphology of poly(l-lactide) formed under high-pressure CO. Macromolecules 2008; 41: 9192-9203.
32. Peng H, et al,. Amphiphilic triblock copolymers of methoxy-poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-lysine) for enhancement of osteoblast attachment and growth. Biomacromolecules 2009; 10: 95-104.
33. Kim YS, et al,. Synthesis and characterization of thermoresponsive-co- biodegradable linear-dendritic copolymers. Macromolecules 2006; 39: 7805-7811. (Pubitemid 44865715)
34. Xie Z, et al,. Triblock poly(lactic acid)-b-poly(ethylene glycol)-b-poly(lactic acid)/paclitaxel conjugates: synthesis, micellization, and cytotoxicity. J Appl Polym Sci 2007; 105: 271-279.
35. Fessi H, et al,. Nanocapsules formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55: R1-R4. (Pubitemid 19247505)
36. Barichello JM, et al,. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm 1999; 25: 471-476. (Pubitemid 29159426)
37. Cheng J, et al,. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007; 28: 869-876. (Pubitemid 44667020)
38. Gao H, et al,. Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-h- cyclodextrin and its properties as the new carrier of protein delivery system. J Control Release 2005; 107: 158-173. (Pubitemid 41253711)
39. Scalia S, Mezzena M,. Incorporation of quercetin in lipid microparticles: effect on photo- and chemical-stability. J Pharmaceut Biomed 2009; 49: 90-94.
40. Ye J, et al,. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm 2008; 352: 273-279. (Pubitemid 351273921)
41. Huo D, et al,. Studies on the poly (lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm 2005; 289: 63-67. (Pubitemid 40093541)
42. Gao H, et al,. Conjugates of poly (DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(β-cyclodextrin)s and their nanoparticles as protein delivery systems. J Control Release 2006; 112: 302-311.
43. Wu TH, et al,. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm 2008; 346: 160-168.
44. Khoee S, et al,. Effects of hydrophobic drug-polyesteric core interactions on drug loading and release properties of poly(ethylene glycol)-polyester-poly(ethylene glycol) triblock core-shell nanoparticles. Nanotechnology 2007; 18: 175602.1-175602.9.
45. Jiang M, et al,. Micelles formed by self-assembly of hyperbranched poly[(amine-ester)-co-(D,L-lactide)] (HPAE-co-PLA) copolymers for protein drug delivery. Polym Int 2009; 58: 31-39.